Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast
- 1 April 1985
- journal article
- research article
- Published by Elsevier in American Journal Of Medicine
- Vol. 78 (4), 555-563
- https://doi.org/10.1016/0002-9343(85)90395-x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Radionuclide angiography and endomyocardial biopsy in the assessment of doxorubicin cardiotoxicityCancer, 1984
- A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin.Journal of Clinical Oncology, 1984
- Weekly doxorubicin in endocrine-refractory carcinoma of the prostate.Journal of Clinical Oncology, 1983
- Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancerCancer, 1982
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982
- Doxorubicin Cardiotoxicity: Assessment of Late Left Ventricular Dysfunction By Radionuclide CineangiographyAnnals of Internal Medicine, 1981
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide AngiocardiographyNew England Journal of Medicine, 1979
- Liquid Chromatographic Analysis of Adriamycin and Metabolites in Biological FluidsJournal of Liquid Chromatography, 1978
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977